Adaptive Cardiac Therapy with Real-time Heart Position State Detection

This inventive concept envisions a next-generation cardiac sensing and therapy system that dynamically adjusts therapy parameters based on real-time heart position state data, leveraging machine learning and artificial intelligence to optimize patient outcomes.

The original patent disclosed a method for controlling delivery of anti-tachyarrhythmia shock therapy based on heart position states. However, this approach has limitations in terms of real-time adaptability and personalization. The new inventive concept addresses these limitations by integrating machine learning engines, wearable devices, and neural networks to provide a more adaptive and effective cardiac therapy system.

The system comprises a cardiac sensing module, a therapy delivery module, and a machine learning engine that dynamically adjusts cardiac therapy parameters based on real-time heart position state data and patient-specific machine learning models. The system can utilize wearable devices to track patient heart position states and wirelessly transmit the data to an implantable medical device, which adjusts cardiac therapy parameters in real-time. Additionally, the system can employ neural networks trained on patient heart position states, cardiac therapy outcomes, and patient-specific characteristics to predict optimal cardiac therapy parameters for a given heart position state.

The new inventive concept introduces the use of machine learning engines, wearable devices, and neural networks to provide real-time adaptability and personalization in cardiac therapy, which is not present in the original patent. The integration of these technologies enables a more effective and efficient cardiac therapy system.

Alternative embodiments of the inventive concept could include the use of swarm intelligence, where multiple micro-sensors implanted in the patient's heart collectively provide real-time heart position state data to an external controller. Another variation could involve the use of genetic algorithms to optimize cardiac therapy parameters for each heart position state.

The adaptive cardiac therapy system has significant commercial potential in the medical device industry, particularly in the areas of cardiac rhythm management and cardiovascular disease treatment. The system's ability to provide personalized and real-time cardiac therapy could lead to improved patient outcomes, reduced healthcare costs, and increased market share for companies that adopt this technology.